The FDA has approved Epidiolex, which contains a purified drug substance cannabidiol, one of more than 80 active chemicals in marijuana, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. That means the FDA has concluded that this particular drug product is safe and effective for its intended indication.
Cannabis use is associated with increased recruitment of task-related areas, such as the dorsolateral prefrontal cortex, which is thought to reflect compensatory activity due to reduced processing efficiency.[113][112][115] Cannabis use is also associated with downregulation of CB1 receptors. The magnitude of down regulation is associated with cumulative cannabis exposure, and is reversed after one month of abstinence.[116][117][118] There is limited evidence that chronic cannabis use can reduce levels of glutamate metabolites in the human brain.[119]
Cannatonic: A potent pain-reliever, Cannatonic hails from Spain and stands as one of the earliest cultivars to be bred for its high CBD content. This cultivar is a cross between MK Ultra and G13 Haze, and it helps relieves anxiety, muscle spasms, pain, and migraines while providing uplifting energy. Cannatonic tends to relax and loosen muscles without locking users to their couches.

There is reasonable evidence from prospective epidemiological studies which suggests that cannabis use can precipitate schizophrenia in persons who are vulnerable because of a personal or family history of schizophrenia. There is also evidence that a genetic vulnerability to psychosis increases the risk that cannabis users will develop psychosis (McGuire et al., 1995; Arseneault et al., 2002; Verdoux et al., 2002). A casual relationship also has biological plausibility in that the cannabinoid and dopaminergic neurotransmitter systems interact in animals. D'Souza and colleagues (1999) have shown in a provocation study that THC produces a dose-dependent increase in psychotic symptoms under double-blind placebo conditions; and Caspi and colleagues (2005) have shown an interaction between specific alleles of the COMT allele and psychotogenic effects of cannabis. If these results can be replicated and extended, they will increase the likelihood that cannabis can be a contributory cause of psychosis in vulnerable individuals.
A 2015 review found that the use of high CBD-to-THC strains of cannabis showed significantly fewer positive symptoms such as delusions and hallucinations, better cognitive function and both lower risk for developing psychosis, as well as a later age of onset of the illness, compared to cannabis with low CBD-to-THC ratios.[278] A 2014 Cochrane review found that research was insufficient to determine the safety and efficacy to using cannabis to treat schizophrenia or psychosis.[279] As of 2017, the molecular mechanisms for the anti-inflammatory and possible pain relieving effects of cannabis are under preliminary research.[280]
The FDA has approved Epidiolex, which contains a purified drug substance cannabidiol, one of more than 80 active chemicals in marijuana, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. That means the FDA has concluded that this particular drug product is safe and effective for its intended indication.
There is reasonable evidence from prospective epidemiological studies which suggests that cannabis use can precipitate schizophrenia in persons who are vulnerable because of a personal or family history of schizophrenia. There is also evidence that a genetic vulnerability to psychosis increases the risk that cannabis users will develop psychosis (McGuire et al., 1995; Arseneault et al., 2002; Verdoux et al., 2002). A casual relationship also has biological plausibility in that the cannabinoid and dopaminergic neurotransmitter systems interact in animals. D'Souza and colleagues (1999) have shown in a provocation study that THC produces a dose-dependent increase in psychotic symptoms under double-blind placebo conditions; and Caspi and colleagues (2005) have shown an interaction between specific alleles of the COMT allele and psychotogenic effects of cannabis. If these results can be replicated and extended, they will increase the likelihood that cannabis can be a contributory cause of psychosis in vulnerable individuals.
What is CBD Pain Freeze? Hemp Bombs CBD Pain Freeze is a premium CBD topical infused with the soothing qualities of Menthol and Camphor Oil. It features the medicinal properties of CBD, or Cannabidiol, which may help relieve inflammation, reduce chronic pain and provide support to your bones, joints and muscles.  CBD Pain Freeze is formulated to absorb deeply without leaving a sticky residue. This deep-penetrating CBD rub is a popular choice among athletes, senior ...
^ El-Alfy, Abir T.; Ivey, Kelly; Robinson, Keisha; Ahmed, Safwat; Radwan, Mohamed; Slade, Desmond; Khan, Ikhlas; Elsohly, Mahmoud; Ross, Samir (2010). "Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L". Pharmacology Biochemistry and Behavior. 95 (4): 573–82. doi:10.1016/j.pbb.2010.03.004. PMC 2866040. PMID 20332000.
The clinical trials performed with Sativex have recently been assessed in two independent review articles (Barnes 2006; Pérez 2006). In a Phase II clinical trial in 20 patients with neurogenic symptoms (Wade et al 2003), Tetranabinex, Nabidiolex, and Sativex were tested in a double-blind RCT vs placebo (Table 1). Significant improvement was seen with both Tetranabinex and Sativex on pain (especially neuropathic), but post-hoc analysis showed symptom control was best with Sativex (p < 0.0001), with less intoxication than with THC-predominant extract.
A a bipartisan group of lawmakers sent a letter to the FDA last week, urging immediate action on the matter. A series of recent actions in New York City, Maine and Ohio cracking down on the sale of CBD foods and drinks have “spurred a tremendous amount of confusion among product manufacturers, hemp farmers, and consumers of these products,” said the letter, as reported by Weedmaps, an information community website for businesses and consumers.
Cannabis use started to become popular in the United States in the 1970s.[251] Support for legalization has increased in the United States and several U.S. states have legalized recreational or medical use.[281] A 2018 Social Science Research study found that the main determinants of such changes in attitudes toward marijuana regulation since the 1990s were changes in media framing of marijuana, a decline in perception of the riskiness of marijuana, a decline in overall punitiveness, and a decrease in religious affiliation. [282]
A clinical endocannabinoid deficiency has been postulated to be operative in certain treatment-resistant conditions (Russo 2004), and has received recent support in findings that anandamide levels are reduced over controls in migraineurs (Sarchielli et al 2006), that a subset of fibromyalgia patients reported significant decreased pain after THC treatment (Schley et al 2006), and the active role of the ECS in intestinal pain and motility in irritable bowel syndrome (Massa and Monory 2006) wherein anecdotal efficacy of cannabinoid treatments have also been claimed.

Information on this website is provided for informational purposes only and is not intended as a substitute for the advice provided by your physician or other healthcare professional. You should not use the information on this website for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment. Any third party offering or advertising on this website does not constitute an endorsement by Andrew Weil, M.D. or Healthy Lifestyle Brands.

CBD is an abbreviation for cannabidiol which is a chemical compound found naturally in the cannabis plant. It contains untraceable amounts of tetrahydrocannabinol (THC), the principal psychoactive element in marijuana which means CBD will NOT get you “high.” In addition, you will not fail any drug tests since these tests do not detect such low levels of THC. Over the past four decades, there have been numerous studies conducted that highlight the potential benefits of CBD.


Our award-winning support staff, experienced cultivators, and network of healthcare practitioners are here to help remove barriers to medical cannabis. We’re honoured to be part of a movement that’s helping Canadians across the country access their medicine; and as we grow we will continue to provide patients with reliable access to safe, consistent, and effective medical cannabis.

A 2016 literature review indicated that cannabidiol was under basic research to identify its possible neurological effects,[11] although as of 2016, there was limited high-quality evidence for such effects in people.[21][96][97] A 2018 meta-analysis compared the potential therapeutic properties of "purified CBD" with full-plant, CBD-rich cannabis extracts with regard to treating refractory (treatment-resistant) epilepsy, noting several differences.[98] The daily average dose of people using full-plant extracts was more than four times lower than of those using purified CBD, a possible entourage effect of CBD interacting with THC.[98]
The legal problems occur once the extracts contain higher percentages of THC, or when they’re made from cannabis plants that are no longer considered “hemp” (so basically high THC plants). Products with these extracts might be in violation of the United States Controlled Substances Act (US CSA). This is when laws regarding specific states or countries will apply. 

In the United States, we're in the middle of a cannabis revolution. Our nation is slowly waking up to the truth that cannabis, what was once dubiously considered a dangerous psychoactive substance, is not only safe but extremely versatile in its medical benefits. This has been reflected in the sales of legal cannabis products, which is expected to grow from $6.6 billion in 2016 to $24.1 billion in 2025.
More recently, Sakamoto and various co-authors[35][36] have used RAPD to isolate several genetic marker sequences that they name Male-Associated DNA in Cannabis (MADC), and which they interpret as indirect evidence of a male chromosome. Several other research groups have reported identification of male-associated markers using RAPD and AFLP.[37][25][38] Ainsworth commented on these findings, stating,
Following an 1836–1840 travel in North Africa and the Middle East, French physician Jacques-Joseph Moreau wrote on the psychological effects of cannabis use; he was a member of Paris' Club des Hashischins.[citation needed] In 1842, Irish physician William Brooke O'Shaughnessy, who had studied the drug while working as a medical officer in Bengal with the East India company, brought a quantity of cannabis with him on his return to Britain, provoking renewed interest in the West.[204] Examples of classic literature of the period featuring cannabis include Les paradis artificiels (1860) by Charles Baudelaire and The Hasheesh Eater (1857) by Fitz Hugh Ludlow.
A 2008 study found, “that a controlled cannabis extract, containing multiple cannabinoids, in a defined ratio, and other non-cannabinoid fractions (terpenes and flavonoids) provided better antinociceptive efficacy than the single cannabinoid given alone…” This is why the use of full-spectrum CBD oil is more effective in treating pain than taking CBD isolate alone – you want the beneficial terpenes and flavonoids contained in the plant.

Zammit and colleagues’ findings were supported in a 3-year longitudinal study of the relationship between self-reported cannabis use and psychosis in a community sample of 4848 people in the Netherlands (van Os et al., 2002). Van Os and colleagues reported that cannabis use at baseline predicted an increased risk of psychotic symptoms during the follow-up period in individuals who had not reported psychiatric symptoms at baseline. There was a dose–response relationship between frequency of cannabis use at baseline and risk of psychotic symptoms during the follow-up period. These relationships persisted when they statistically controlled for the effects of other drug use. The relationship between cannabis use and psychotic symptoms was also stronger for cases with more severe psychotic symptoms.
What a great article on CBD oils which only touches the surface of its benefits!! Only thing I disagree upon is it mentions CBD not containing any psychotropics. CBD oil requires a touch of THC to properly work. If the solution is strong enough and people take more than necessary one can get s little “high” for reals. A tiny amount of CBD oil goes a long way, especially when you have the oils directly produced from squeezing the oils from CBD prominent plants. Sativa plants often have a higher THC component than Indica plants and Sativa plants are smoked for their “get up and go properties “ rather than the more relaxing kick back Indica plants
When elected to the presidency of the RACGP he said, “I will be passionate and vocal in advocating for primary healthcare and look forward to the challenge ahead”. Dr Seidel we hope that you can rise to the challenge of introducing Medicinal Cannabis to the mainstream of General Practice through education and encouragement of your peers. We strongly welcome you and thank you for your participation at this symposium.
About 49% of the weight of hempseed is an edible oil[7] that contains 76% as essential fatty acids; i.e., linoleic acid, omega-6 (LA, 54%), alpha-linolenic acid, omega-3 (ALA, 17%), in addition to gamma-linolenic acid (GLA, 3%), monounsaturated fat (5% to 11%), and stearidonic acid (2%).[8] Hemp seed oil contains 5% to 7% saturated fat.[7][8] In common with other oils, hempseed oil provides 9 kcal/g. Compared with other culinary oils it is low in saturated fatty acids.[8]
First of all, you need to know that CBD oil can come from both the hemp plant and from medical marijuana.  Both of those plants are different varieties of cannabis but they’re much different in the terms of chemical compounds they have.  Medical marijuana is good for people with certain ailments because it does contain the THC and it can contain any varying level of the THC or any varying level of CBD.

Cannabis

×